pharmaphorum October 13, 2020
George Underwood

Ayming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably promising” despite strong headwinds caused by COVID-19.

The report reveals that R&D departments are being empowered by the creation of ‘innovation ecosystems’, new funding methods, and the deployment of technology.

Ayming surveyed a combination of 330 business executives and R&D managers from 13 countries across North America and Europe. The report covers three sections: The Innovation Landscape, Financing Innovation and Sustainable Innovation.

The report’s authors say that R&D teams remain resolute in the face of several key obstacles.

“Not only has COVID-19 caused expectations for budget increases to decline 12%, but complexity is making it increasingly difficult to innovate successfully, international competition...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Investments, Public Health / COVID, Survey / Study, Technology, Trends
5 tips on AI adoption from a frontline physician champion
Government policies needed for full interoperability in senior care, experts argue
US federal agencies must have a chief AI officer under new order
AI expertise gets more expensive as hospitals bulk up
America's new innovation hotspots, mapped

Share This Article